Smith & Nephew plc (SNN)
Market Cap | 12.14B |
Revenue (ttm) | 5.22B |
Net Income (ttm) | 223.00M |
Shares Out | 436.68M |
EPS (ttm) | 0.51 |
PE Ratio | 54.58 |
Forward PE | 16.50 |
Dividend | $0.38 (1.38%) |
Ex-Dividend Date | Sep 29, 2022 |
Volume | 547,788 |
Open | 27.81 |
Previous Close | 28.04 |
Day's Range | 27.67 - 27.96 |
52-Week Range | 21.78 - 34.12 |
Beta | 0.35 |
Analysts | Buy |
Price Target | 33.22 (+19.45%) |
Earnings Date | Feb 28, 2023 |
About SNN
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform m... [Read more]
Financial Performance
In 2022, Smith & Nephew's revenue was $5.22 billion, an increase of 0.06% compared to the previous year's $5.21 billion. Earnings were $223.00 million, a decrease of -57.44%.
Financial StatementsAnalyst Forecast
According to 21 analysts, the average rating for SNN stock is "Buy." The 12-month stock price forecast is $33.22, which is an increase of 19.45% from the latest price.
News

Smith & Nephew's (SNN) CIT Technology Favored by New Study
Smith & Nephew (SNN) achieves a positive response for its COBLATION-Technology-infused Intracapsular Tonsillectomy Technique, providing fast patient recovery over existing surgeries.

New evidence demonstrates Smith+Nephew's COBLATION™ Technology can accelerate patient recovery with fewer complications compared with total tonsillectomy techniques
LONDON , March 23, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces results from new scientific research that shows its COBLATION Intracapsu...

Smith & Nephew (SNN) Simplifies ACL Surgery With New Offers
Smith & Nephew (SNN) introduces QUADTRAC System and broadens ULTRABUTTON Adjustable Fixation Devices portfolio for ACL reconstruction.

Smith+Nephew to highlight procedural innovations in Sports Medicine during AAOS 2023 Annual Meeting
LONDON , March 8, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN) (NYSE:SNN), the global medical technology company, today announces it will showcase its latest Sports Medicine procedural innovations for j...

Smith+Nephew unveils 'Precision in Motion' for its Orthopaedics Arthroplasty portfolio at AAOS 2023 Annual Meeting
An uncompromising commitment to freedom of movement LONDON , March 7, 2023 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, today unveils "Precision in Motion"...

Smith+Nephew Sports Medicine advances procedural innovation by launching the QUADTRAC™ Quadriceps Tendon Harvest Guide System and expanded family of ULTRABUTTON™ Adjustable Fixation Devices for ACL reconstruction
LONDON , March 7, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today introduced the UltraTRAC™ QUAD ACL Reconstruction Technique which consists of the n...

Smith+Nephew's VISIONAIRE™ Patient-Specific Instrumentation shown to improve outcome measures for total knee arthroplasty compared with conventional instrumentation
LONDON , March 6, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces a systemic literature review and meta-analysis1 of its VISIONAIRE Patient...

What Makes Smith & Nephew (SNN) a New Buy Stock
Smith & Nephew (SNN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Smith+Nephew receives Innovative Technology designation from Vizient for LEAF™ Patient Monitoring System
Designation recognizes Vizient-contracted products that bring improvements to healthcare industry LONDON , Jan. 30, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology ...

Smith & Nephew Is Reverting to Fair Value
The medical device industry has undergone considerable consolidation in recent years, leaving a small number of competitors, and offers long-term growth potential due to increasing longevity, an aging...

Smith+Nephew expands procedural innovation with introduction of JOURNEY™ II ROX™ Total Knee Solution
LONDON , Nov. 1, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the introduction of its JOURNEY II ROX Total Knee Solution – a reverse hyb...

Smith+Nephew first to market with revision knee indication on robotics platform
LONDON , Sept. 26, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the first cases for revision knee replacement utilizing its CORI◊ Surgic...

Smith+Nephew Academy expands global access to professional medical education through virtual reality and other advanced simulation technologies
LONDON , Sept. 21, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it is expanding the reach of its medical education curriculum through a ...

New randomized controlled trial shows that addition of Smith+Nephew's REGENETEN™ Bioinductive Implant delivers 86% reduction in rotator cuff re-tear rates at 12 months
LONDON , Sept. 14, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE: SNN), the global medical technology company, today announces promising new data furthering a number of published studies supporting ...

Smith & Nephew: A Medical Equipment Opportunity
FTSE 100 constituent and medical equipment maker Smith & Nephew PLC ( SNN , Financial) ( LSE:SN. , Financial) seemed to be making progress after its 2021 results in February.

Smith+Nephew's OXINIUM™ Technology Tour of Change touches down at the Pro Football Hall of Fame during enshrinement weekend
LONDON , Aug. 4, 2022 /PRNewswire/ -- Smith+Nephew (LSE: SN) (NYSE: SNN), the global medical technology company, today announces that the OXINIUM Technology Tour of Change mobile exhibit will make a s...

Smith+Nephew to showcase latest innovations for sports medicine joint repair at 2022 AOSSM Annual Meeting
LONDON , July 13, 2022 /PRNewswire/ -- Smith+Nephew (LSE: SN) (NYSE: SNN), the global medical technology company, today announces a robust line-up featuring several of its advanced joint repair soluti...

Smith+Nephew launches Clinical Support App to help reduce practice variation in wound care
LONDON , July 12, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of the WOUND COMPASS™ Clinical Support App. The WOUND COMPASS ...

Smith+Nephew announces first robotic-assisted surgery using its LEGION™ CONCELOC™ Cementless Total Knee System
LONDON , June 30, 2022 /PRNewswire/ -- Smith+Nephew (LSE: SN), (NYSE: SNN), the global medical technology company, today announces the first robotic-assisted surgery using its LEGION CONCELOC Cementle...

SMITH+NEPHEW SHARES NEW RESEARCH THAT ESTIMATES 3.5 BILLION HOURS OF NURSE TIME COULD BE RELEASED BY 2030 THROUGH SHARED WOUND CARE AND USE OF LONG-WEAR ADVANCED FOAM DRESSINGS
LONDON , June 14, 2022 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology business, announces the publication of a new peer-reviewed article in Wounds International . The...

Smith+Nephew announces first total hip replacement cases on its CORI™ Surgical System using RI.HIP MODELER and RI.HIP NAVIGATION
LONDON , June 8, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces that the first total hip arthroplasty (THA) procedure using RI.HIP MODELE...

Healiva® Acquires Two Wound-healing Cell Therapy Assets From Smith+Nephew
LUGANO, Switzerland--(BUSINESS WIRE)-- #celltherapy--Healiva®, a patient-centric company delivering life-enhancing precision medicine for patients with chronic and acute wounds, announced today the ac...

Smith & Nephew Posts Q1 Sales Growth As Elective Procedures Rebound
Smith & Nephew PLC (NYSE: SNN) posted Q1 revenue of $1.31 billion, up 3.3% on a reported basis (including -2.6% currency effect) and up 5.9% on an underlying basis. Sports Medicine & ENT revenue up 8....

Smith+Nephew announces new study showing GRAFIX™ Membrane cut the rate of diabetic foot ulcer recurrence in half compared to leading competitors
LONDON , March 31, 2022 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology business, announces the publication of a peer-reviewed study in the Advances in Wound Care Jour...

Smith+Nephew to showcase latest Orthopaedic advancements in Cementless Knees, Total Hip Arthroplasty and Robotics at AAOS 2022 Annual Meeting
LONDON , March 22, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces it will it showcase its latest innovations for Orthopaedic Reconstructi...